Novartis Investigative Site

Luoyang, Henan 471003

0 studies enrolling now · 5 studies all time

What they study most

IgA Nephropathy, Lipoprotein Disorder, Primary IgA Nephropathy, Primary Immune Thrombocytopenia (ITP), Primary Prevention of Atherosclerotic Cardiovascular Disease

Studies at this site

• A Study of DII235 in Adults With Elevated Lipoprotein(a) — Running, not enrolling
• A Rollover Extension Program (REP) to Evaluate the Long-term Safety and Tolerability of Open Label Iptacopan/LNP023 in Participants With Primary IgA Nephropathy — Running, not enrolling
• A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients. — Running, not enrolling
• Study of Ianalumab Versus Placebo in Addition to First-line Corticosteroids in Primary Immune Thrombocytopenia (ITP) — Running, not enrolling
• Study of Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients — Completed